PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 189 results · Cardiovascular  · Clear
🔒 Subscribers only
AUTH/3388/9/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous member of the public complained about alleged promotion of prescription-only medicines (POMs) Lixiana (edoxaban), Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) on a …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3409/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous, non-contactable complainant (described as a concerned healthcare professional) complained about a promotional email and video about Lixiana (edoxaban) in NVAF, said to have been sent …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3417/11/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous, contactable patient found a YouTube video (a recording of a meeting held on 8 July 2020) on a page run by a medical education company; the complainant believed it was sponsored by Dai…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3396/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo breached ABPI Code over out-of-date competitor safety symbol in Nilemdo FOC scheme ma
An anonymous Sanofi employee complained (in a personal capacity) about Daiichi-Sankyo promotional material for Nilemdo (bempedoic acid) used in a virtual meeting about a free-of-charge (FOC) scheme…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3446/12/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Jazz Pharmaceuticals
An anonymous, non-contactable complainant (self-described health professional) challenged content on the Sunosi (solriamfetol) HCP website (sunosi.co.uk). They alleged external hyperlinks (MHRA Yel…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3425/11/20
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AUTH/3425/11/20 & AUTH/3426/11/20
The Royal College of General Practitioners (RCGP) Overdiagnosis Group complained about a promotional email for Eliquis (apixaban) (ref PP-ELI-GBR-6974) sent jointly by Pfizer Limited and Bristol-My…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3400/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Code over third‑party video series seen as pre‑licence promotion of inclisiran (AU
An anonymous health professional complained about a roundtable video series on a UK-based third-party cardiology website that included clinical data on inclisiran (Leqvio) before it had a marketing…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3329/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
A UK health professional complained about the pradaxa.co.uk landing page, which showed two routes: one for UK health professionals and one for “Patients Prescribed Pradaxa/Members of the Public�…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3301/1/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Vifor
An anonymous, contactable complainant alleged the ivironheart.co.uk website (ref UK-NP-1900153, Sept 2019) was disguised promotion of Vifor’s Ferinject (ferric carboxymaltose) and that it was not…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3321/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
A Menarini breached Clause 12.1 after PDF supplement lacked clear upfront company involvement (Ranex
A UK health professional complained that a supplement hosted on the Guidelines in Practice website and produced by A Menarini was disguised promotion for Ranexa (ranolazine).The item was titled: �…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3322/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
A UK health professional complained about two videos hosted on the ‘Guidelines in Practice’ website: ‘Secondary event prevention and risk stratification in patients with symptomatic periphera…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3293/1/20
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim breached ABPI Code over Pradaxa 110mg website claim implying use in “any patien
An anonymous health professional complained about promotion of Pradaxa (dabigatran) by Boehringer Ingelheim Limited.The complaint focused on the claim: “recommended for use in any patient at incr…
Clauses: 4.1,4.3
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3391/9/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Sanofi
A UK health professional complained about a banner advertisement on Sanofi’s UK health-professional-only Praluent (alirocumab) promotional website.The banner showed runners and the headline: “H…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3170/3/19
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
An anonymous, contactable health professional (a GP) complained about a consultant cardiologist’s presentation on Entresto (sacubitril/valsartan) at a Novartis-organised and sponsored speaker mee…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3246/9/19
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer and Bristol-Myers Squibb
A concerned UK health professional complained about promotion of Eliquis (apixaban) by Pfizer Limited and Bristol-Myers Squibb Pharmaceuticals Limited (the Alliance).The material appeared on the Pu…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3215/6/19
Off-label Promotion Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GP v Pfizer and Bristol-Myers Squibb
A general practitioner complained about a page from a six-page, landscape, gatefold leavepiece promoting Eliquis (apixaban) (ref PP-ELI-GBR-4453) issued by Pfizer Limited and Bristol-Myers Squibb P…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3162/2/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca
A UK health professional complained about AstraZeneca re-tweeting a US-origin tweet from the global @AstraZeneca account during Heart Failure Awareness Week 2019.The tweet promoted awareness of hea…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3155/2/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol-Myers Squibb & Pfizer
A UK health professional complained about the Eliquis (apixaban) health professional website section on special warnings and precautions for use.The page advised care when Eliquis was used with NSA…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3180/4/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca sales manager’s personal Instagram post about KOL nurse ruled in scope and unethical; co
A respiratory nurse complained about Facebook/Instagram posts made from an AstraZeneca UK sales manager’s personal social media accounts.The posts referred to a named nurse (nurse A), described a…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3142/1/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Sanofi
An anonymous complainant (professional status unknown) challenged an online advertisement/“advertorial” for Praluent (alirocumab) placed by Sanofi on the HSJ (Health Service Journal) website.Th…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3242/9/19
HCP Hospitality & Meetings Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
An anonymous, contactable complainant raised concerns about hospitality linked to UK health professionals attending the European Society of Cardiology (ESC) Congress in Paris (31 Aug–4 Sep 2019).…
Clauses: 22.2
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3270/10/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
A UK health professional complained about Bayer’s UK website for Xarelto (rivaroxaban), a prescription only medicine.The landing page had two routes: one for UK healthcare professionals and one f…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3289/12/19
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol Myers Squibb and Pfizer
A UK health professional complained about prescribing information (PI) attached to a promotional email for Eliquis (apixaban) received in December 2019.The PI was last revised in July 2019, while t…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3283/11/19
Transfers of Value Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer
What happened A senior pharmacist at a clinical commissioning group (CCG) complained about the conduct of representatives at a GP practice meeting to promote Eliquis (apixaban), co-promoted by Bris…
Clauses: 15,2,7,8
2019 🔒 Subscribe
← Prev 1 2 3 4 5 6 Next → Page 3 of 8 — 189 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews